STRYKER CORPORATION for STRYKER CORPORATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
S. 232 The Medical Device access and Innovation Protection Act and H.R. 523, the Protect Medical Innovation Act - to repeal the 2.3% excise tax on medical devices
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAGE KRANBUHL | Senate HELP Subcommittee staff |
| NATHANIEL FRANK TIPTON | Legislative Director Congressional Office |
Health Issues HCR
Implementation of Public Law 112-144: The Food and Drug Administration Safety and Improvement Act H.R. 3303, the Software Act - FDA regulation of health information technology, mobile medical applications and software Telehealth legislation Energy & Commerce Committee 21st Century Cures Initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAGE KRANBUHL | Senate HELP Subcommittee staff |
| NATHANIEL FRANK TIPTON | Legislative Director Congressional Office |
Medicare/Medicaid MMM
Implementation of Public Law 111-148, the Patient Protetion and Affordable Care Act, particularly accountable care organizations and bundled payment models. Meeting with Medicare to discuss reassignment of neurovascular procedures to different DRGs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAGE KRANBUHL | Senate HELP Subcommittee staff |
| ERIC RUGO | — |
| NATHANIEL FRANK TIPTON | Legislative Director Congressional Office |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.